Where the material comes from
Almost every polynucleotide product on the UK market begins as fish. That fact is rarely prominent on a clinic page and it changes several decisions.

The polynucleotide material in the injectable products sold in the United Kingdom is, in the overwhelming majority of cases, extracted from fish, most commonly salmon or trout. The usual source tissue is the milt or gonadal tissue, which is unusually rich in DNA.
The extracted DNA is then purified to remove proteins, lipids and other cellular debris, fragmented to a controlled size range, sterilised and put into solution. Purification is the step that manufacturers rely on when they describe the finished product as free of the fish proteins that cause fish allergy. It is a real and substantial process. It is not the same as a guarantee, and the correct thing to do with a fish allergy is to raise it explicitly and in advance.
1.2.1Why fish, and why that tissue
The choice is practical rather than mystical. Milt is one of the most DNA dense tissues available in quantity from an animal already farmed and processed at industrial scale. It is a by product of an existing food industry, it is cheap, it is available in consistent volume, and the extraction chemistry is well understood. Salmon and trout dominate because of aquaculture supply chains rather than because of any special property of salmonid DNA.
Marketing sometimes implies that salmon DNA is particularly similar to human DNA, or particularly compatible with human tissue. The first part is true in a trivial sense, because DNA is chemically the same molecule in every organism on earth, built from the same four bases. That is the point: the material is species agnostic at the chemical level, which is precisely why the source species is a manufacturing decision rather than a biological one. A page that presents salmon as biologically special is selling the source, not explaining it.
1.2.2What purification is for
Everything that causes a problem in a biological extract is a contaminant rather than the target molecule. The purification stages are designed to strip out three categories in particular.
- Protein. Fish allergy is an allergy to specific fish proteins, principally parvalbumin. Removing protein is the central purification objective, both for allergy and because protein contamination is an immunological risk in any injectable.
- Endotoxin and microbial material. Any injectable derived from animal tissue has to be brought below defined endotoxin limits and rendered sterile. This is a routine but non trivial part of manufacturing.
- Lipids and cellular debris. These affect the physical behaviour of the solution and are removed for both safety and consistency.
The point of stating this is not to reassure. It is to give you something specific to ask about. A practitioner who understands the product they are injecting should be able to say which manufacturer made it, whether it carries a UKCA or CE mark, and what the instructions for use say about allergy and contraindications. A practitioner who responds to a question about fish allergy with a general reassurance rather than a reference to the product documentation has told you something about the depth of their preparation.
1.2.3Allergy, and how to raise it
If you have a diagnosed fish allergy, particularly one that has produced a significant reaction, this is a conversation to have with a clinician before you are anywhere near a treatment room, and it is reasonable to ask for it to be documented. The NHS pages on allergy and anaphylaxis are the right starting point for understanding what a significant reaction means, and a history of anaphylaxis to any trigger changes the risk calculus of every elective injectable procedure.
Two nuances are worth carrying. First, an allergy to shellfish is a different allergy to a fish allergy, and the two are frequently confused in consultations. Second, the absence of reported allergic reactions to a class of product is weaker evidence than it appears, because reporting of adverse events in the private cosmetic sector is voluntary and incomplete. The MHRA Yellow Card scheme accepts reports about medical devices as well as medicines, and members of the public can report directly.
1.2.4Diet, religion and belief
People avoid animal derived products for many reasons and most of them are not medical. A vegetarian or vegan patient is entitled to know that the product is fish derived before they consent, and a consent process that does not surface it has failed on its own terms rather than on ideological ones. The same applies to patients whose religious practice restricts animal products or requires particular slaughter and handling, and to patients who simply would rather not.
There is no established plant derived or synthetic equivalent in routine cosmetic use in the United Kingdom that we can point you to, and a clinic that offers one should be asked directly what the product is, who makes it and what its regulatory status is. The answer to that question is more informative than the answer to almost any other.
1.2.5Supply chain and what you cannot see
Between the fish and the syringe there is a manufacturer, a distributor and often a reseller. Injectable products in the aesthetic sector are sold through channels of varying formality, and products that are not intended for the UK market do circulate. The single most useful protective question is whether the product carries a UKCA or CE mark and whether the clinic can show you the packaging and the instructions for use.
This is not an abstract concern about paperwork. A marked product from a named manufacturer, bought through a legitimate distributor, has a traceable chain and a route for reporting problems. A product bought outside that chain has neither, and if something goes wrong the person who has to establish what was injected is you.
1.2.6Sustainability, briefly and without invention
The material is a by product of aquaculture, which means its environmental footprint is bound up with the footprint of fish farming rather than being separate from it. We are not going to quantify that, because doing so would require figures we cannot substantiate for this specific use. What we will say is that any clinic page presenting the treatment as environmentally virtuous because it uses a by product is making an argument that would need the whole supply chain accounted for before it meant anything.
1.2.7What to ask
- Which manufacturer makes the product you intend to use, and what is it called?
- Is it UKCA or CE marked, and may I see the packaging and the instructions for use?
- What does the manufacturer's documentation say about fish allergy?
- Does this product contain anything besides polynucleotides and buffer, for example hyaluronic acid or an anaesthetic?
- Where did you buy it from?
None of those questions is confrontational and all of them have short factual answers. A practitioner who is comfortable with their own supply chain will answer them without any difficulty at all.
Questions
Can I have this treatment if I am allergic to fish?
That is a question for a clinician who knows your allergy history, not for a website. Raise it explicitly and early, ask what the manufacturer's instructions for use say about it, and treat a general reassurance that is not grounded in the product documentation as an incomplete answer. A history of anaphylaxis to any trigger changes the risk calculation for every elective injectable.
Is there a vegan version?
We are not aware of an established plant derived or synthetic polynucleotide injectable in routine UK cosmetic use. If a clinic offers one, ask what the product is, who manufactures it and whether it carries a UKCA or CE mark, and treat vagueness on those points as significant.
Does shellfish allergy matter here?
Shellfish allergy and fish allergy are different allergies to different proteins, and they are often conflated in consultations. Say precisely what you are allergic to and let the clinician work from that rather than from a category.
How do I know the product is genuine?
Ask to see the packaging and the instructions for use, ask for the manufacturer's name, and ask where the clinic buys it. A UKCA or CE marked product from a named manufacturer through a legitimate distributor has a traceable chain and a reporting route. Anything else leaves you carrying the burden of proof if something goes wrong.
Can I report a problem with a product myself?
Yes. The MHRA Yellow Card scheme takes reports from members of the public about medical devices as well as medicines, and you do not need your clinic's permission or agreement to make one.
- MHRA Yellow Card scheme
- Medical devices: regulation and safety, gov.uk
- NHS, Allergies
- NHS, Anaphylaxis
- The Medical Devices Regulations 2002
Links to regulators, professional bodies, legislation and research indexes. They are cited because they are public and checkable, not as endorsement of this publication. No source listed here has any commercial relationship with us.
Revisions to this document
This reference is revised when the evidence changes. Subscribe and you will be told what was revised, what the verdict was before, and what it is now.
One email when this document is revised, with what changed and why. Any sponsor line is labelled as such and can never influence an evidence verdict. Rates are published on the newsletter page. We do not sell, share or rent the list. Unsubscribe from any email.